Posted by Michael Wonder on 08 May 2018
Notification of delay of decision on denosumab funding proposal
8 May 2018 - PHARMAC would like to advise all interested parties that there will be a delay in the decision on a proposal to fund denosumab 60 mg prefilled syringed for the treatment of osteoporosis.
The proposal was the subject of a consultation dated 16 March 2018.
Consultation on this proposal closed on 4 April. Some significant issues were raised in consultation responses and we require additional time to consider them before a decision can be made on the proposal.
